CA2372197A1 - Functionalized heterocycles as chemokine receptor modulators - Google Patents

Functionalized heterocycles as chemokine receptor modulators Download PDF

Info

Publication number
CA2372197A1
CA2372197A1 CA002372197A CA2372197A CA2372197A1 CA 2372197 A1 CA2372197 A1 CA 2372197A1 CA 002372197 A CA002372197 A CA 002372197A CA 2372197 A CA2372197 A CA 2372197A CA 2372197 A1 CA2372197 A1 CA 2372197A1
Authority
CA
Canada
Prior art keywords
methyl
carboxylic acid
benzopyrano
quinolizine
decahydro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002372197A
Other languages
English (en)
French (fr)
Inventor
Christine Nylund Kolz
Yuntao Song
Jay R. Luly
Bruce David Roth
Bharat Kalidas Trivedi
Geraldine C. Harriman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Millennium Pharmaceuticals Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2372197A1 publication Critical patent/CA2372197A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D455/00Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/02Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing not further condensed quinolizine ring systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • AIDS & HIV (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
CA002372197A 1999-01-13 1999-12-20 Functionalized heterocycles as chemokine receptor modulators Abandoned CA2372197A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11565499P 1999-01-13 1999-01-13
US60/115,654 1999-01-13
PCT/US1999/030434 WO2000042045A2 (en) 1999-01-13 1999-12-20 Functionalized heterocycles as chemokine receptor modulators

Publications (1)

Publication Number Publication Date
CA2372197A1 true CA2372197A1 (en) 2000-07-20

Family

ID=22362668

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002372197A Abandoned CA2372197A1 (en) 1999-01-13 1999-12-20 Functionalized heterocycles as chemokine receptor modulators

Country Status (20)

Country Link
EP (1) EP1144415A2 (pt)
JP (1) JP2002534526A (pt)
KR (1) KR20010086166A (pt)
CN (1) CN1344270A (pt)
AP (1) AP2001002228A0 (pt)
AU (1) AU1940900A (pt)
BR (1) BR9916905A (pt)
CA (1) CA2372197A1 (pt)
CZ (1) CZ20012502A3 (pt)
EA (1) EA200100774A1 (pt)
HK (1) HK1044539A1 (pt)
HU (1) HUP0202932A3 (pt)
IL (1) IL144289A0 (pt)
MX (1) MXPA01007033A (pt)
NO (1) NO20013456L (pt)
OA (1) OA11820A (pt)
PL (1) PL349348A1 (pt)
SK (1) SK9972001A3 (pt)
WO (1) WO2000042045A2 (pt)
ZA (1) ZA200106592B (pt)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002072549A1 (en) * 2001-03-12 2002-09-19 Millennium Pharmaceuticals, Inc. Functionalized heterocycles as modulators of chemokine receptor function and methods of use therefor
EP1379239B1 (en) * 2001-03-29 2007-09-12 Eli Lilly And Company N-(2-arylethyl) benzylamines as antagonists of the 5-ht6 receptor
WO2003035650A1 (fr) * 2001-09-25 2003-05-01 Takeda Chemical Industries, Ltd. Inhibiteur d'entree
JP4736043B2 (ja) 2003-03-14 2011-07-27 小野薬品工業株式会社 含窒素複素環誘導体およびそれらを有効成分とする薬剤
WO2004092169A1 (ja) 2003-04-18 2004-10-28 Ono Pharmaceutical Co., Ltd. スピロピペリジン化合物およびその医薬用途
TWI400232B (zh) 2004-09-13 2013-07-01 Ono Pharmaceutical Co 含氮雜環衍生物及以該含氮雜環衍生物為有效成分之藥劑
JPWO2006129679A1 (ja) 2005-05-31 2009-01-08 小野薬品工業株式会社 スピロピペリジン化合物およびその医薬用途
WO2007031838A1 (en) 2005-09-16 2007-03-22 Ranbaxy Laboratories Limited Substituted pyrazolo [3,4-b] pyridines as phosphodiesterase inhibitors
EP2657235A1 (en) 2005-10-28 2013-10-30 Ono Pharmaceutical Co., Ltd. Compound containing basic group and use thereof
ES2407115T3 (es) 2005-11-18 2013-06-11 Ono Pharmaceutical Co., Ltd. Compuesto que contiene un grupo básico y uso del mismo
CN101460458A (zh) 2006-02-15 2009-06-17 阿勒根公司 具有1-磷酸-鞘氨醇(s1p)受体拮抗剂生物活性的带芳基或者杂芳基基团的吲哚-3-羧酸的酰胺、酯、硫代酰胺和硫羟酸酯化合物
NZ570528A (en) * 2006-02-15 2011-09-30 Allergan Inc Indole-3-carboxylic acid amide, ester, thioamide and thiol ester compounds bearing aryl or heteroaryl groups having sphingosine-1-phosphate (s1p) receptor antagonist biological activity
AU2007225836A1 (en) 2006-03-10 2007-09-20 Ono Pharmaceutical Co., Ltd. Nitrogenated heterocyclic derivative, and pharmaceutical agent comprising the derivative as active ingredient
US8618122B2 (en) 2006-05-16 2013-12-31 Ono Pharmaceutical Co., Ltd. Compound having acidic group which may be protected, and use thereof
EP2036889A4 (en) * 2006-05-23 2009-11-04 Alla Chem Llc SUBSTITUTED INDOLES AND PROCESS FOR PRODUCTION AND USE THEREOF
JP5245827B2 (ja) 2006-07-31 2013-07-24 小野薬品工業株式会社 スピロ結合した環状基を含有する化合物およびその用途
US8524917B2 (en) 2007-01-11 2013-09-03 Allergan, Inc. 6-substituted indole-3-carboxylic acid amide compounds having sphingosine-1-phosphate (S1P) receptor antagonist biological activity
JP2010515750A (ja) * 2007-01-11 2010-05-13 アラーガン インコーポレイテッド スフィンゴシン−1−ホスフェート(s1p)受容体アンタゴニスト生物活性を有する6−置換インドール−3−カルボン酸アミド化合物
WO2010129351A1 (en) 2009-04-28 2010-11-11 Schepens Eye Research Institute Method to identify and treat age-related macular degeneration
CA2799154A1 (en) 2010-05-12 2011-11-17 Abbvie Inc. Indazole inhibitors of kinase
US20140271680A1 (en) 2011-08-12 2014-09-18 Universite Paris-Est Creteil Val De Marne Methods and pharmaceutical compositions for treatment of pulmonary hypertension
JO3459B1 (ar) 2012-09-09 2020-07-05 H Lundbeck As تركيبات صيدلانية لعلاج مرض الزهايمر
CN104193669B (zh) * 2014-08-01 2016-12-07 大连理工大学 一类阿比朵尔类似物或其盐、其制备方法及应用
WO2016112088A1 (en) * 2015-01-06 2016-07-14 Spero Therapeutics, Inc. Aryloxyacetylindoles and analogs as antibiotic tolerance inhibitors
CN110256324A (zh) * 2019-06-13 2019-09-20 苏州莱安医药化学技术有限公司 一种2-甲基-5-羟基吲哚的制备方法
US11629196B2 (en) 2020-04-27 2023-04-18 Incelldx, Inc. Method of treating SARS-CoV-2-associated hypercytokinemia by administering a human monoclonal antibody (PRO-140) that inhibits CCR5/CCL5 binding interactions

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3549641A (en) * 1966-06-28 1970-12-22 Warner Lambert Pharmaceutical Pyrano pyridines and process for their production
US3518258A (en) * 1967-05-09 1970-06-30 Warner Lambert Pharmaceutical Pyrano(3,2-i)quinolizine and process for the production
US3565903A (en) * 1967-11-24 1971-02-23 Warner Lambert Pharmaceutical Pyrano(2,3-b)quinolines and process for their production
US5635510A (en) * 1993-05-06 1997-06-03 Merrell Pharmaceuticals Inc. Substituted pyrrolidin-3-yl-alkyl-piperidines
HRP960352A2 (en) * 1996-07-26 1998-08-31 Pliva Pharm & Chem Works Novel coumarin quinoline carboxylic acids
CN1248968A (zh) * 1997-02-26 2000-03-29 辉瑞大药厂 杂芳基-己酸酰胺衍生物、其制备方法及其作为MIP-1α与其CCRI受体结合的选择性抑制剂的用途
JP2002501898A (ja) * 1998-02-02 2002-01-22 メルク エンド カムパニー インコーポレーテッド ケモカイン受容体活性の環状アミン調節剤

Also Published As

Publication number Publication date
MXPA01007033A (es) 2003-07-21
AU1940900A (en) 2000-08-01
SK9972001A3 (en) 2002-03-05
OA11820A (en) 2005-08-17
IL144289A0 (en) 2002-05-23
BR9916905A (pt) 2002-01-29
PL349348A1 (en) 2002-07-15
CN1344270A (zh) 2002-04-10
NO20013456D0 (no) 2001-07-12
JP2002534526A (ja) 2002-10-15
EA200100774A1 (ru) 2002-02-28
EP1144415A2 (en) 2001-10-17
WO2000042045A2 (en) 2000-07-20
ZA200106592B (en) 2002-08-12
CZ20012502A3 (cs) 2002-03-13
HUP0202932A3 (en) 2003-07-28
WO2000042045A3 (en) 2000-11-09
NO20013456L (no) 2001-09-12
HK1044539A1 (zh) 2002-10-25
AP2001002228A0 (en) 2001-09-30
KR20010086166A (ko) 2001-09-08
HUP0202932A2 (hu) 2002-12-28

Similar Documents

Publication Publication Date Title
CA2372197A1 (en) Functionalized heterocycles as chemokine receptor modulators
Harayama et al. Synthesis of trisphaeridine and norchelerythrine through palladium-catalyzed aryl–aryl coupling reactions
JP3241381B2 (ja) 三環性キノキサリンジオン化合物
JPH06503095A (ja) 三環式ポリヒドロキシ系のチロシンキナーゼ阻害薬
JPH0386875A (ja) アザビシクロキノロンカルボン酸
Meyers et al. A facile synthesis of chiral bicyclic lactams utilized in the formation of chiral quaternary carbon compounds
EA004140B1 (ru) β-КАРБОЛИНОВЫЕ СОЕДИНЕНИЯ, СПОСОБ ИХ ПОЛУЧЕНИЯ И ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, ИХ СОДЕРЖАЩАЯ
Marinelli Generation and cycloaddition reactions of indole-2, 3-quinodimethanes
PL85030B1 (pt)
AU674746B2 (en) 4-arylisoindole analgesics
DE69629341T2 (de) Pyrrolocarbazolderivate
DE4130933A1 (de) Neue (beta)-carbolinderivate, deren herstellung und verwendung in arzneimitteln
Carly et al. Diels-Alder reactions of pyridine o-quinodimethane analogues generated from functionalised o-bis (chloromethyl) pyridines
Molina et al. Fused carbazoles by tandem Aza Wittig/electrocyclic ring closure. Preparation of 6H-pyrido [4, 3-b] carbazole, 11H-pyrido [4, 3-a] carbazole and 11H-pyrido [3, 4-a] carbazole derivatives
CS249126B2 (en) Method of substituted hexahydropyrrolo-(1,2-a)quinolines,hexahydro-1h-pyrido(1,2-a)quinolines and octahydrophenanthrenes production
EP0222703A1 (de) Hexahydro-[1]-benzo-(pyrano und thiopyrano)-[4,3-c]pyridine
Tadic et al. Probes for narcotic receptor mediated phenomena. Part 31: Synthesis of rac-(3R, 6aS, 11aS)-2-methyl-1, 3, 4, 5, 6, 11a-hexahydro-2H-3, 6a-methanobenzofuro [2, 3-c] azocine-10-ol, and azocine-8-ol, the ortho-c and the para-c oxide-bridged phenylmorphan isomers
US4996211A (en) Substituted dibenzocycloheptenimines
KR910002564B1 (ko) 헥사하이드로피롤로[2,1-a]이소퀴놀린 유도체의 제조방법
DE3300522A1 (de) 3,3-dialkyl- und 3,3-alkylen-indolinderivate, verfahren zu ihrer herstellung und pharmazeutische praeparate sie enthaltend
US3583997A (en) Benzothiopyrano(2,3-c)pyridines
FI69076C (fi) Foerfarande foer framstaellning av farmaceutiskt anvaendbara oktahydro-1h-benso(4,5)furo(3,2-e)isokinolinderivat samt av farmaceutiskt godtagbara syraadditionssalter av dessa
US5912365A (en) Derivatives of 2-azabicyclo 2.2.1! heptane, their preparation and their application
GB2051048A (en) Geminal Dihalogen Derivatives of Condensed Pyrimidin-4-one Compounds their Preparation and Pharmaceutical Compositions Containing them
US5587486A (en) 1-amino-2-cyclohexene derivative and production process therefor

Legal Events

Date Code Title Description
FZDE Discontinued